testicular cancer	is a	germ cell tumor
testicular cancer	includes	seminoma
testicular cancer	includes	non-seminomatous germ cell tumor
seminoma	is a	germ cell tumor
non-seminomatous germ cell tumor	is a	germ cell tumor
non-seminomatous germ cell tumor	includes	embryonal carcinoma
non-seminomatous germ cell tumor	includes	yolk sac tumor
non-seminomatous germ cell tumor	includes	choriocarcinoma
non-seminomatous germ cell tumor	includes	teratoma
testicular cancer	presents with	scrotal mass
testicular cancer	presents with	testicular lump
testicular cancer	predominantly affects	young men
cryptorchidism	is a	risk factor for testicular cancer
family history	is a	risk factor for testicular cancer
testicular cancer	diagnosed by	scrotal ultrasound
testicular cancer	diagnosed by	tumor markers
AFP	is a	tumor marker for testicular cancer
hCG	is a	tumor marker for testicular cancer
LDH	is a	tumor marker for testicular cancer
non-seminomatous germ cell tumor	elevates	AFP
non-seminomatous germ cell tumor	elevates	hCG
non-seminomatous germ cell tumor	elevates	LDH
seminoma	treated with	radiotherapy
seminoma	responds to	radiotherapy
testicular cancer	treated with	orchiectomy
orchiectomy	followed by	surveillance
testicular cancer	treated with	chemotherapy
testicular cancer	treated with	BEP regimen
BEP regimen	includes	bleomycin
BEP regimen	includes	etoposide
BEP regimen	includes	cisplatin
non-seminomatous germ cell tumor	treated with	platinum-based chemotherapy
platinum-based chemotherapy	leads to	tumor shrinkage
testicular cancer	may cause	infertility
fertility preservation	recommended for	patients with testicular cancer
sperm banking	is option for	fertility preservation
sperm cryopreservation	is option for	fertility preservation
testicular cancer	has	favorable prognosis
testicular cancer	has	high cure rate
staging	uses	retroperitoneal lymph node assessment
retroperitoneal lymph node dissection	used for	residual disease
RPLND	provides	staging information
tumor markers	monitored for	disease status
surveillance	follows	orchiectomy
surveillance	includes	regular tumor marker testing
testicular cancer	risk factors	cryptorchidism
contralateral testis	at risk for	second primary tumor
age at diagnosis	influences	prognosis
testicular cancer	peak incidence in	young adults
testicular cancer	most often affects	one testis
testicular cancer	can be	unilateral
ultrasound	detects	testicular mass
CT scan	used for	staging of testicular cancer
chest CT	used for	staging of testicular cancer
abdomen CT	used for	staging of testicular cancer
RPLND	provides	disease control in non-seminomatous tumor
chemotherapy	reduces	distant metastasis
radiotherapy	reduces	local recurrence
stage I seminoma	treated with	adjuvant radiotherapy
stage I seminoma	may be treated with	surveillance
stage II disease	treated with	radiotherapy or chemotherapy
stage III disease	treated with	chemotherapy
platinum-based chemotherapy	improves	survival
bleomycin	is component of	BEP regimen
etoposide	is component of	BEP regimen
cisplatin	is component of	BEP regimen
testicular cancer	recurrence risk	depends on stage
testicular cancer	prognosis	depends on stage and histology
testicular cancer	prognosis	favorable with early detection
testicular cancer survivors	require	long-term follow-up
survivorship care	includes	tumor marker monitoring
sperm banking	enables	fertility preservation
fertility preservation	supports	future fertility
hypogonadism	may result from	orchiectomy
hypogonadism	managed with	testosterone therapy
hCG elevation	signals	choriocarcinoma component
AFP elevation	signals	yolk sac or embryonal component
LDH elevation	signals	tumor burden
imaging	used for	relapse detection
tumor marker testing	part of	surveillance protocol
intrinsic chemosensitivity	is high for	germ cell tumors
platinum sensitivity	is high for	germ cell tumors
brain metastases	are rare in	testicular cancer
bone metastases	are rare in	testicular cancer
sperm count	may recover after	chemotherapy
fertility outcomes	depend on	histology
seminoma radiotherapy	reduces	relapse rate
radiotherapy increases	risk of secondary malignancy
sperm banking	recommended before	chemotherapy
inguinal orchiectomy	approach for	removal of testis
inguinal orchiectomy	is preferred for	suspected testicular cancer
biopsy	not recommended for	suspected testicular cancer
stage II disease	requires	combination therapy
stage III disease	requires	combination therapy
testicular cancer	surveillance schedule	frequency after treatment
tumor markers	may normalize	after therapy
surveillance imaging	includes	CT scans
survival	is high	with early treatment
histology	influences	treatment plan
practice guidelines	support	multidisciplinary care
